Pages that link to "Q46167685"
Jump to navigation
Jump to search
The following pages link to The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains (Q46167685):
Displaying 25 items.
- Antibody Engineering Using Phage Display with a Coiled-Coil Heterodimeric Fv Antibody Fragment (Q28740649) (← links)
- Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm (Q30980477) (← links)
- Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody (Q31814859) (← links)
- Stability engineering of scFvs for the development of bispecific and multivalent antibodies (Q33574335) (← links)
- A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo (Q33688219) (← links)
- Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors. (Q34626991) (← links)
- Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach (Q35764163) (← links)
- Identifying bottlenecks in transient and stable production of recombinant monoclonal-antibody sequence variants in Chinese hamster ovary cells (Q36089255) (← links)
- Engineered Autonomous Human Variable Domains (Q36140177) (← links)
- Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex (Q36147049) (← links)
- Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires (Q36905073) (← links)
- RosettaAntibody: antibody variable region homology modeling server (Q37245729) (← links)
- Engineering the variable region of therapeutic IgG antibodies. (Q37853324) (← links)
- Molecular engineering of antibodies for therapeutic and diagnostic purposes (Q38017581) (← links)
- Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv. (Q38906090) (← links)
- Novel multispecific heterodimeric antibody format allowing modular assembly of variable domain fragments (Q41837643) (← links)
- Determinants of the assembly and function of antibody variable domains (Q42143637) (← links)
- Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides. (Q43439472) (← links)
- Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions (Q45161404) (← links)
- Antibody Heavy Chain Variable Domains of Different Germline Gene Origins Diversify through Different Paths (Q47133855) (← links)
- An integrated approach to extreme thermostabilization and affinity maturation of an antibody (Q56891850) (← links)
- Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design (Q58781552) (← links)
- Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics (Q90212119) (← links)
- Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody (Q90723419) (← links)
- Germinality does not necessarily define mAb expression and thermal stability (Q92216145) (← links)